Upregulated TROAP predicts the poor OS and DFS in patients with adrenocortical carcinoma, kidney renal clear cell carcinoma, pancreatic adenocarcinoma, skin cutaneous melanoma and HCC. Here, TROAP is linked to cutaneous melanoma.